Potassium Chloride

ANDA 86713, held by Abraxis Pharm. Potassium Chloride.

As of Nov 15, 2026, ANDA 86713 (Potassium Chloride), held by Abraxis Pharm, was not approved, with 5 approved supplements and 0 published complete response letters.

First approved: Not approved
Supplements approved: 5
Complete response letters: 0

Products

1 strengths and forms

Product	Active ingredient	Marketing
Potassium Chloride2MEQ/ML · injectable;injection	Potassium Chloride	Discontinued

All 5 submissions, including labeling and manufacturing supplements


Jan 23, 1987	Supplement 5Manufacturing	Approved	None posted
Dec 6, 1984	Supplement 4Manufacturing	Approved	None posted
Sep 12, 1984	Supplement 3Manufacturing	Approved	None posted
Dec 16, 1983	Supplement 2Manufacturing	Approved	None posted
Mar 23, 1982	Supplement 1Manufacturing	Approved	None posted

Identifiers

Application: ANDA 86713
Drugs@FDA: Overview at FDA
Company: Abraxis Pharmaceuticals

Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters